Linio Biotech

Linio Biotech is a Finnish regenerative medicine company focused on developing innovative solutions for skin regeneration and repair. The company's core technology, TissuLin, is an injectable, human-derived extracellular matrix (ECM) designed to restore damaged or aged skin by promoting natural tissue growth. Linio Biotech targets applications in both medical aesthetics, such as scar revision and skin rejuvenation, and clinical wound care for chronic or hard-to-heal wounds. By leveraging a proprietary manufacturing process that preserves the natural structure of the ECM, the company aims to provide a superior alternative to synthetic fillers and traditional skin grafts. The product is currently marketed for aesthetic applications in select European markets while undergoing further clinical evaluation for medical indications.